A clinical trial of mithramycin in the treatment of advanced malignant disease
- PMID: 4873186
- PMCID: PMC2008246
- DOI: 10.1038/bjc.1968.25
A clinical trial of mithramycin in the treatment of advanced malignant disease
Similar articles
-
Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.Cancer Treat Rep. 1979 Jan;63(1):139-40. Cancer Treat Rep. 1979. PMID: 369686 Clinical Trial. No abstract available.
-
[Results of clinical study of the antineoplastic antibiotic rubomycin].Antibiotiki. 1968 Sep;13(9):846-50. Antibiotiki. 1968. PMID: 4884477 Russian. No abstract available.
-
Phase II study of pyrazofurin in advanced colorectal carcinoma.Cancer Treat Rep. 1977 May-Jun;61(3):491-3. Cancer Treat Rep. 1977. PMID: 872147 No abstract available.
-
Summary of clinical data on antitumor antibiotics in Japan.Recent Results Cancer Res. 1978;63:1-19. doi: 10.1007/978-3-642-81219-4_1. Recent Results Cancer Res. 1978. PMID: 360329 Review.
-
Breast cancer and acute leukemia: report of 24 cases and review of the literature.Am J Hematol. 1978;4(2):151-72. doi: 10.1002/ajh.2830040207. Am J Hematol. 1978. PMID: 354377 Review. No abstract available.
Cited by
-
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer.Biomedicines. 2021 Jan 12;9(1):70. doi: 10.3390/biomedicines9010070. Biomedicines. 2021. PMID: 33445667 Free PMC article. Review.
-
The Hypomethylating Agent 5-Azacitidine Potentiates the Effect of RAS and Sp1 Inhibitors in Neuroblastoma Cells.Acta Naturae. 2025 Apr-Jun;17(2):86-97. doi: 10.32607/actanaturae.27558. Acta Naturae. 2025. PMID: 40771851 Free PMC article.
-
Mithramycin A Enhances Tumor Sensitivity to Mitotic Catastrophe Resulting From DNA Damage.Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):344-352. doi: 10.1016/j.ijrobp.2017.09.049. Epub 2017 Oct 12. Int J Radiat Oncol Biol Phys. 2018. PMID: 29157749 Free PMC article.
-
Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters.Mol Pharmacol. 2019 Aug;96(2):158-167. doi: 10.1124/mol.118.114827. Epub 2019 Jun 7. Mol Pharmacol. 2019. PMID: 31175181 Free PMC article.
-
Integrative analysis of transcriptome, DNA methylome, and chromatin accessibility reveals candidate therapeutic targets in hypertrophic cardiomyopathy.Protein Cell. 2024 Nov 1;15(11):796-817. doi: 10.1093/procel/pwae032. Protein Cell. 2024. PMID: 38780967 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources